2020
DOI: 10.1007/s40290-020-00345-w
|View full text |Cite
|
Sign up to set email alerts
|

Using Data from the Canadian Post-marketing Spontaneous Pharmacovigilance System for Drug Safety Research: A Feasibility Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…[12][13][14] Nevertheless, the limitations of the data should be understood in interpreting the results obtained from the SRS, since the SRS is a passive reporting system that is liable to over-reporting, underreporting, missing data on patient characteristics, exclusion of healthy subjects, missing denominators, and the presence of confounding factors. 15,16) In this study, we applied the ROR as a signal to find unknown correlations between adverse events and drugs. Notably, the ROR is an indicator of increased risk of adverse events and does not represent the absolute risk of occurrence of adverse events.…”
Section: Discussionmentioning
confidence: 99%
“…[12][13][14] Nevertheless, the limitations of the data should be understood in interpreting the results obtained from the SRS, since the SRS is a passive reporting system that is liable to over-reporting, underreporting, missing data on patient characteristics, exclusion of healthy subjects, missing denominators, and the presence of confounding factors. 15,16) In this study, we applied the ROR as a signal to find unknown correlations between adverse events and drugs. Notably, the ROR is an indicator of increased risk of adverse events and does not represent the absolute risk of occurrence of adverse events.…”
Section: Discussionmentioning
confidence: 99%
“…In terms of transparency, our final dataset is available to the public. Our group has previously worked on validating the methodologies for using Canada Vigilance data in research, boosting confidence in the quality of the information [ 1 ]. Despite these strengths, some limitations were unavoidable.…”
Section: Discussionmentioning
confidence: 99%
“…At the point of data extraction (January 2020), data were available from 1 January 1965 to 31 October 2019. The method for using this source of data for applied pharmacovigilance studies has been previously published [ 1 ]. The Statistics Canada database provides the annual Canadian population since 1965, but only since 1971 specifically for female and male Canadians [ 40 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation